From Europe. For the global patent community.
Trending Topics:
JUVE Patent Biotechnology

Biotechnology

People & Business
Promosome, BioNTech, Pfizer, COVID-19, Comirnaty
mRNA technology

Battle over COVID-19 vaccines reaches UPC as Promosome sues BioNTech

The dispute over mRNA technology has now reached the UPC. After BioNTech's COVID-19 vaccine Comirnaty was attacked in national courts by Moderna and C ...

7 February 2025 by Konstanze Richter
Cases
Celltrion, Novartis, Genentech, Xolair, UK, biosimilar
Biosimilars

Bristows successful for Novartis against Celltrion's UK invalidity claim over Xolair

In the dispute with Celltrion over the asthma drug omalizumab, the UK High Court has ruled in favour of Novartis and Genentech. The two patent holders ...

5 February 2025 by Mathieu Klos
People & Business
df-mp Dörries Frank-Molnia & Pohlman, litigation, UPC
Germany

df-mp hones structure to focus entirely on litigation

With a new firm structure and a focus on life sciences and hi-tech, the IP firm df-mp is concentrating entirely on patent litigation and strengthening ...

4 February 2025 by Konstanze Richter
People & Business
Claudia Hertzsch, Hoyng ROKH Monegier, König Szynka, Hoffmann Eitle, Düsseldorf
Germany

Hoyng ROKH expands patent attorney practice with König Szynka partner

Claudia Hertzsch joins Hoyng ROKH Monegier on 1 April, where she will continue to focus on patent litigation. Her previous firm König Szynka Tilmann v ...

28 January 2025 by Mathieu Klos
People & Business
Hoffmann Eitle, König Szynka, Smorodin, Düsseldorf, Munich
Germany

Hoffmann Eitle and König Szynka unite top pharma teams

A new heavyweight in the life sciences sector is emerging in Germany. The Düsseldorf team of König Szynka Tilmann von Renesse is to join Hoffmann Eitl ...

14 January 2025 by Mathieu Klos
Cases
CRISPR/Cas, gene-cutting, genetic scissors, Nobel prize
CRISPR/Cas

Swerving the matter of granting genetic scissor patents at the EPO

This autumn, the EPO Boards of Appeal were supposed to issue landmark decisions in the battle for the basic patents on CRISPR/Cas9 technology. But the ...

28 November 2024 by Mathieu Klos
Sponsored Content Legal Commentary

Should pharma and biotech companies now be embracing the UPC?

Should pharma and biotech companies now be embracing the UPC? At this joint event hosted by Pinsent Masons and JUVE Patent, a group of industry lea ...

25 November 2024 by Pinsent Masons LLP
Cases
Pfizer, uniQure, haemophilia
Gene therapy

uniQure successfully defends haemophilia gene therapy patent against Pfizer

Pfizer may not launch its haemophilia gene therapy drug on the UK market. The UK High Court recently rejected a revocation claim by Pfizer against a p ...

12 November 2024 by Konstanze Richter
Sponsored Content Legal Commentary

Lifesciences Patent Litigation & Remedies

Turkiye has a specialized court system and provides for all commonly known civil law measures to enforce or defend against IP claims. The court system…

30 October 2024 by JUVE
Sponsored Content This article provides a detailed look into patentability and enforcement in lifesciences indusrty in Turkiye.

LIFESCIENCES PATENT MATTERS IN TURKIYE

This article provides a detailed look into patentability and enforcement in lifesciences indusrty in Turkiye.

30 October 2024 by JUVE
Cases
NanoString, 10x Genomics, Bird & Bird, central division Munich, UPC
Medical devices

NanoString and Bird & Bird triumph against 10x Genomics at central division

NanoString has achieved a win in its dispute with 10x Genomics over diagnostic devices at the UPC. The central division Munich has now revoked one of ...

18 October 2024 by Konstanze Richter
Cases
Novo Nordisk, semaglutide, opposition, weight-loss, diabetes
Blockbuster drug

Generic drug companies attack Novo Nordisk's diabetes and weight-loss drug

The Boards of Appeal of the European Patent Office have revoked two patents belonging to Novo Nordisk that are important for the administration of the ...

11 October 2024 by Mathieu Klos
Cases
CureVac, BioNTech, Pfizer, mRNA, covid
mRNA vaccines

Setback for CureVac in the UK

CureVac has suffered a setback in its dispute with BioNTech and Pfizer over mRNA patents. The UK High Court declared two patents invalid this week. If ...

10 October 2024 by Mathieu Klos
Cases
Plant protection patents

Syngenta obtains UPC injunction against Sumi Agro for herbicide

The UPC Munich local division issued a clear injunction in the dispute between two companies from the plant protection industry and upheld the patent. ...

5 September 2024 by Christina Schulze
Cases
Samsung Bioepsis, Janssen, Stelara, ustekinumab
Biosimilars

Samsung Bioepis destroys Stelara patent with Simmons & Simmons

Janssen is fighting Samsung Bioepis in Europe over its blockbuster drug Stelara. In the UK revocation claim the High Court has now declared a patent i ...

12 August 2024 by Konstanze Richter
Popular